Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

H James Cavanaugh


  • Large Shareholder, Director at Leap Therapeutics Inc. (LPTX), 2019-06-12
  • Other at Globeimmune Inc (GBIM), 2016-02-19
  • Large Shareholder at Proteostasis Therapeutics Inc. (PTI), 2016-02-17
  • Large Shareholder at Trevena Inc (TRVN), 2014-02-07
  • Large Shareholder at Tetralogic Pharmaceuticals Corp (TLOG), 2013-12-17
  • Director at Verenium Corp (VRNM), 2013-11-04
  • Large Shareholder at Radius Health Inc. (NONE), 2011-12-23
  • Large Shareholder, Director at Pharmathene Inc (PIP), 2010-11-05
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
VRNM $3.08 37,305 Director 187,305 2011-09-15 Filing
VRNM $3.10 50,000 Director 150,000 2011-09-14 Filing
VRNM $1.95 54,000 Director 100,000 2011-08-15 Filing
VRNM $1.74 21,200 Director 46,000 2011-08-12 Filing
VRNM $3.21 9,800 Director 24,800 2011-03-15 Filing